A study in The American Society for Microbiology co-authored by Dr. Richard Slayded shows that a new drug therapy can kill a variety of mycobacterial species of bacteria, including those that cause tuberculosis.

CSU researchers expanded their neurovirology work to include anti-inflammatory drug therapies for COVID-19. Colorado State University is one of a small number of universities where this research can take place.

Dr. Slayden explains the purpose of the Center for Environmental Medicine.

Dr. Ric Slayden talks about the RIC building and functional genomics research.